Homovanillic Acid (HVA) ELISA is for Research Use Only. Not for diagnostic procedures.
EagleBio’s Homovanillic Acid (HVA) ELISA was recently utilized in an study by National Institute of Neurological Disorders and Stroke.
Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease
Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by the loss of dopamine neurons in the substantia nigra, decreased striatal dopamine levels, and consequent extrapyramidal motor dysfunction. Recent evidence indicates that cyclin-dependent kinase 5 (Cdk5) is inappropriately activated in several neurodegenerative conditions, including PD. Read more